Organovo (NASDAQ:ONVO) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Organovo (NASDAQ:ONVO) in a note issued to investors on Saturday. The firm set a “sell” rating on the medical research company’s stock.

Organovo Price Performance

ONVO stock opened at $0.39 on Friday. Organovo has a 1 year low of $0.32 and a 1 year high of $1.74. The firm has a market capitalization of $5.93 million, a PE ratio of -0.36 and a beta of 0.54. The business has a 50 day simple moving average of $0.38 and a 200-day simple moving average of $0.45.

About Organovo

Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.